[1] BIEDRZYCKI M, DAHLING H, CHEMICINICKL P. Methodof preparing Erythromycin A cyclic 11,12-carbonate[P]. EP0119431,1984-09-26. [2] MURPHY HW, STEPHENS VC, CONINE JW.Erythromycin derivative and process for the preparation thereof[P]. US3,417,077,1968. [3] SONG DQ, GAO LM, ZHANG ZP.Synthesis of erythromycin A 11, 12-cyclic carbonate[J]. Chinese Journal of Antibiotics(中国抗生素杂志) , 2001, 26(4): 248-249, 253. [4] YOU XF, LOU RH, ZHANG WX, et al.In vitro antibacterial activity of erythromycin cyclic 11,12-carbonate[J]. Chinese Journal of Antibiotics(中国抗生素杂志) , 2003, 28(8): 482-487. [5] YOU XF, ZHANG WX, LOU RH, et al.In vivo antibacterial activity of erythromycin cyclic 11,12-carbonate[J]. Chinese Journal of Antibiotics(中国抗生素杂志) , 2003, 28(8): 488-490. [6] LIN JJ, LIN J.Effect of erythromycin cyclocarbonate on mycoplasma pneumonia in children and improvement of clinical symptoms[J]. Chin J of Clinical Rational Drug Use(临床合理用药杂志), 2022, 15(11): 142-145. [7] YU ZP, WANG HB, HE YF, et al.Efficacy and safety of erythromycin cyclocarbonate for suspension in the treatment of mild pneumonia in children[J]. Chin J Clin Res(中国临床研究), 2021, 34(12): 1645-1647. [8] SHEN J.Observation on the curative effect and adverse reactions of erythromycin cyclocarbonate dry suspension in the treatment of acute respiratory tract infection in children[J]. Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine(中西医结合心血管病杂志), 2019, 7(2): 164-167. [9] WANG FL, LI J.Effect of erythromycin cyclocarbonate and azithromycin in sequential treatment of children with mycoplasma pneumonia complicated with mycoplasemia[J]. Clinical Research and Practice(临床医学研究与实践), 2018, 3(22): 73-74. [10] LI ZY.Study on clinical effect of Xiaoer Feike granules combined with erythromycin cyclocarbonate in the treatment of children with acute bronchitis[J]. Clinical Medicine & Engineering(临床医学工程), 2021, 28(5): 639-640. [11] LI JY, GE FL, CAO JL, et al.Clinical characteristics and rationality of drug usage in antibiotic agents related liver injury[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(11): 1020-1024. [12] LIN FF, CHEN XY, HUANG XJ, et al.Determination of erythromycin cyclic 11, 12-carbonate in human plasma by LC-MS/MS method[J]. Chin Pharm J(中国药学杂志), 2010, 45(13): 1020-1023. [13] YANG GP, OU YANG DS, CHEN BM, et al.Bioequivalence study of erythromycin cyclic 11,12- carbonate powder suspension, capsule and tablet[J]. Clin J New Drugs Clin Rem(中国新药与临床杂志), 2007,26(4): 245-248. [14] SUN PH, ZHOU Y, CUI YM, et al.Pharmacokinetic study of erythromycin Cyclic 11,12-carbonate tablets[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2002, 18(4): 277-280. [15] NIE ZL, LIU CP, WANG XL, et al.Study on determination method for dissolution of erythromycin cyclic11,12-carbonate tablets[J]. Journal of Chengdu University (Natural Science Edition)(成都大学学报自然科学版), 2013, 32(2): 116-120. [16] SLAWINSKI W, BOJARSKA-DAHLIG H, GLABSKI T, et al.The structure of erythromycin A cyclic carbonate[J]. J R Neth Chem Soc, 1975, 94(11): 236. |